期刊
PHARMACOLOGY
卷 106, 期 5-6, 页码 286-293出版社
KARGER
DOI: 10.1159/000512117
关键词
Doxorubicin; Cyclophosphamide; N-acetylcysteine; Cognitive impairment; Anxiety
资金
- Ministry of Education, Culture, Sports, Science, and Technology of Japan [15K08589]
- Grants-in-Aid for Scientific Research [15K08589] Funding Source: KAKEN
The study found that the antioxidant N-acetylcysteine can reverse the anxiety-like behavior and cognitive impairment induced by the combination treatment of doxorubicin and cyclophosphamide. The medication not only affects the behavior of rats, but also has an impact on the oxidative stress levels in the hippocampus.
Background: Cancer patients can suffer from psychological and cognitive disorders after chemotherapy, which influence quality of life. Objective: Oxidative stress may contribute to the psychological and cognitive disorders induced in rats by chemotherapy. In the present study, we examined the effects of N-acetylcysteine, an anti-oxidant, on anxiety-like behavior and cognitive impairment in rats treated with a combination of doxorubicin and cyclophosphamide. Methods: Rats were intraperitoneally injected with doxorubicin and cyclophosphamide once a week for 2 weeks. The light-dark test and the novel location recognition test were used to assess anxiety-like behavior and spatial cognition, respectively. The rats' hippocampal levels of glutathione (GSH) and glutathione disulfide (GSSG) were measured using a GSSG/GSH quantification kit. Results: Combined treatment with doxorubicin and cyclophosphamide produced anxiety-like behavior and cognitive impairment in rats. N-acetylcysteine reversed the anxiety-like behavior and inhibition of novel location recognition induced by the combination treatment. Furthermore, the combination of doxorubicin and cyclophosphamide significantly reduced the rats' hippocampal GSH/GSSG ratios. N-acetylcysteine reversed the reduction in the GSH/GSSG ratio seen in the doxorubicin and cyclophosphamide-treated rats. Conclusion: These results suggest that N-acetylcysteine inhibits doxorubicin and cyclophosphamide-induced anxiety-like behavior and cognitive impairment by reducing oxidative stress in the hippocampus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据